182 related articles for article (PubMed ID: 35534342)
21. Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.
Grąt M; Kornasiewicz O; Lewandowski Z; Hołówko W; Grąt K; Kobryń K; Patkowski W; Zieniewicz K; Krawczyk M
World J Surg; 2014 Oct; 38(10):2698-707. PubMed ID: 24858191
[TBL] [Abstract][Full Text] [Related]
22. Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation.
Al-Ameri AAM; Wei X; Lin L; Shao Z; Guo H; Xie H; Zhou L; Zheng S; Xu X
BMC Cancer; 2019 Nov; 19(1):1136. PubMed ID: 31752756
[TBL] [Abstract][Full Text] [Related]
23. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
Sarkar M; Dodge JL; Roberts JP; Terrault N; Yao F; Mehta N
Ann Hepatol; 2016; 15(4):545-9. PubMed ID: 27236153
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
[TBL] [Abstract][Full Text] [Related]
25. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
26. Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Hong G; Suh KS; Suh SW; Yoo T; Kim H; Park MS; Choi Y; Paeng JC; Yi NJ; Lee KW
J Hepatol; 2016 Apr; 64(4):852-9. PubMed ID: 26658686
[TBL] [Abstract][Full Text] [Related]
27. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
28. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A
Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778
[TBL] [Abstract][Full Text] [Related]
29. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
[TBL] [Abstract][Full Text] [Related]
30. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
[TBL] [Abstract][Full Text] [Related]
31. Impact of Histological Factors of Hepatocellular Carcinoma on the Outcome of Liver Transplantation.
Donat M; Alonso S; Pereira F; Ferrero E; Carrión L; Acin-Gándara D; Moreno E
Transplant Proc; 2016; 48(6):1968-77. PubMed ID: 27569930
[TBL] [Abstract][Full Text] [Related]
32. Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma.
He L; Ji WS; Jin HL; Lu WJ; Zhang YY; Wang HG; Liu YY; Qiu S; Xu M; Lei ZP; Zheng Q; Yang XL; Zhang Q
World J Gastroenterol; 2024 Jun; 30(21):2763-2776. PubMed ID: 38899335
[TBL] [Abstract][Full Text] [Related]
33. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.
Han K; Tzimas GN; Barkun JS; Metrakos P; Tchervenkov JL; Hilzenrat N; Wong P; Deschênes M
Can J Gastroenterol; 2007 Jan; 21(1):39-45. PubMed ID: 17225881
[TBL] [Abstract][Full Text] [Related]
34. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.
Tabrizian P; Holzner ML; Mehta N; Halazun K; Agopian VG; Yao F; Busuttil RW; Roberts J; Emond JC; Samstein B; Brown RS; Najjar M; Chapman WC; Doyle MM; Florman SS; Schwartz ME; Llovet JM
JAMA Surg; 2022 Sep; 157(9):779-788. PubMed ID: 35857294
[TBL] [Abstract][Full Text] [Related]
35. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
36. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.
Liu B; Teng F; Fu H; Guo WY; Shi XM; Ni ZJ; Gao XG; Ma J; Fu ZR; Ding GS
BMC Gastroenterol; 2015 Oct; 15():138. PubMed ID: 26472203
[TBL] [Abstract][Full Text] [Related]
37. Early Detection of Hepatocellular Carcinoma Recurrence in the Posttransplant Population: A Comparison of RETREAT and Cleveland Clinic Florida Scoring System.
Hasan B; Colak Y; Khalid RA; Castillo M; Castaneda D; Tandon K; Shaw JJ; Erim T; Zervos XB; Castro FJ; Al-Khalloufi K
Transplant Proc; 2021; 53(1):193-199. PubMed ID: 33069486
[TBL] [Abstract][Full Text] [Related]
38. A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
Wang ZX; Song SH; Teng F; Wang GH; Guo WY; Shi XM; Ma J; Wu YM; Ding GS; Fu ZR
Clin Transplant; 2010; 24(6):752-7. PubMed ID: 20030683
[TBL] [Abstract][Full Text] [Related]
39. Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation.
Goldaracena N; Mehta N; Scalera I; Sposito C; Atenafu EG; Yao FY; Muiesan P; Mazzaferro V; Sapisochin G
HPB (Oxford); 2019 Jun; 21(6):731-738. PubMed ID: 30391218
[TBL] [Abstract][Full Text] [Related]
40. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
Bhangui P; Saigal S; Gautam D; Piplani T; Choudhary N; Chaudhary R; Yadav S; Thiagarajan S; Rastogi A; Saraf N; Nundy S; Soin AS
Liver Transpl; 2021 Feb; 27(2):209-221. PubMed ID: 33253492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
